Table 1.
Variables | Cases | miRNA-324-3p | WNT2B mRNA | WNT2B protein |
---|---|---|---|---|
Sex | ||||
Male | 28 | 0.717 ± 0.463 | 1.028 ± 0.461 | 1.001 ± 0.369 |
Female | 11 | 0.613 ± 0.245 | 1.052 ± 0.305 | 1.010 ± 0.320 |
Age | ||||
<45 | 19 | 0.731 ± 0.386 | 1.055 ± 0.372 | 1.008 ± 0.301 |
≥45 | 20 | 0.647 ± 0.443 | 1.016 ± 0.468 | 0.999 ± 0.402 |
T stage | ||||
T3 + T4 | 9 | 0.476 ± 0.296 | 1.306 ± 0.324 | 1.312 ± 0.340 |
T1 + T2 | 30 | 0.751 ± 0.426* | 0.953 ± 0.414* | 0.911 ± 0.303** |
Clinic stage | ||||
III + IV | 23 | 0.466 ± 0.283 | 1.237 ± 0.341 | 1.199 ± 0.304 |
I + II | 16 | 1.006 ± 0.362** | 0.743 ± 0.347** | 0.722 ± 0.187** |
Lymph node metastasis | ||||
Yes | 28 | 0.539 ± 0.324 | 1.171 ± 0.316 | 1.099 ± 0.284 |
No | 11 | 1.067 ± 0.381** | 0.687 ± 0.461** | 0.761 ± 0.403* |
Data was shown as mean ± SD. miR-324-3p, WNT2B mRNA and protein were normalized with the internal control U6, GAPDH and β-Actin, respectively
* P < 0.05
** P < 0.01